Testosterone Therapy Demonstrates CV Safety in Testosterone Deficiency
Testosterone therapy was not associated with an increased risk for cardiovascular events among patients with testosterone deficiency.
Related Articles
Elect Officer & Member, National Board of Directors Positions | ADA
Explore officer and board of directors positions at the ADA. Join us in making a difference for millions of Americans with diabetes and their support…
Experience evolves into evidence in the new MEN1 guidelines
Nearly a quarter of a century has passed since the publication of the first clinical practice guideline on multiple endocrine neoplasia type 1 (MEN1) in…
Treatments for MEN1-associated endocrine tumours: three systematic reviews and a meta-analysis
In patients with MEN1, subtotal parathyroidectomy achieved greater reductions in persistence and recurrence of primary hyperparathyroidism than less than subtotal parathyroidectomy; for non-functioning pancreatic neuroendocrine…
Multiple endocrine neoplasia type 1 (MEN1): recommendations and guidelines for best practice
Multiple endocrine neoplasia type 1 (MEN1) is characterised by combined occurrence of parathyroid tumours, duodenopancreatic neuroendocrine tumours, and anterior pituitary adenomas. Some patients might also…
INNOVATIVE SCIENCE TO TRANSFORMATIONAL CARE
The preeminent international conference for obesity researchers and clinicians, ObesityWeek® is home to the latest developments in evidence-based obesity science: cutting-edge basic and clinical research,…
Cardiovascular Care for Transgender and Gender-Diverse Patients
Dr Joshua D Safer and Dr C Streed Jr discuss the importance of cardiovascular care among transgender and gender-diverse patients.
GLP1-RAs May Benefit Psychiatric Outcomes, Quality of Life
GLP-1RAs were associated with improved quality of life and emotional eating behaviors among individuals with overweight and obesity.
BMI, Waist Circumference Differentially Linked to T2D Complications
BMI and WC were differentially associated with microvascular and macrovascular complications among patients with type 2 diabetes.
83rd Scientific Sessions | American Diabetes Association
There are companies that are claiming to offer registration services for ADA’s Scientific Sessions, which are not affiliated with ADA and do not offer any…
Transforming Lives with Action | ADA
Find out how our advocacy supports diabetes research funding, health care access. Become an advocate and help us ensure a bright future for those living…
